Skip to main content
INSTITUTO ROSENBUSCH S.A. DE BIOLOGÍA E Y A logo

INSTITUTO ROSENBUSCH S.A. DE BIOLOGÍA E Y A — Investor Relations & Filings

BYMA Manufacturing
Filings indexed 1,010 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country AR Argentina
Listing BYMA

About INSTITUTO ROSENBUSCH S.A. DE BIOLOGÍA E Y A

https://www.rosenbusch.com/

Instituto Rosenbusch S.A. de Biología E y A is a long-established company with over a century of experience in the animal health sector. It specializes in the production and commercialization of a comprehensive line of biological and pharmaceutical products for veterinary use. As a pioneer in the biologics business, the company's portfolio includes various vaccines and pharmaceuticals, such as the Equine Rhinopneumonitis vaccine, which is indicated for the prevention of equine rhinopneumonitis and viral abortion caused by Herpes Virus I and IV.

Recent filings

Filing Released Lang Actions
HECHO RELEVANTE - OBSERVACIÓN EFECTUADA POR LA GERENCIA TÉCNICA Y DE VALORES NEGOCIABLES DE LA BOLSA DE COMERCIO DE BUENOS AIRES RESPECTO DE LO RESUELTO EN EL PUNTO 4° DEL ORDEN DEL DÍA DE LA ASAMBLEA
Regulatory Filings Classification · 85% confidence The document is a “Hecho Relevante” (material event) filed with the Comisión Nacional de Valores and the Buenos Aires Stock Exchange. It does not contain financial statements, voting results, or executive compensation details, nor is it an investor presentation or report publication notice. It is a regulatory announcement about a Board decision in response to a technical observation by the exchange’s technical management group. This falls into the catchall category for general regulatory filings.
2026-05-20 Spanish
FEC. CELEB.: 12-05-2026 - TEMA: 6 - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Regulatory Filings Classification · 65% confidence The document is a board meeting minute (‘Acta de Directorio’) of Instituto Rosenbusch S.A. It records a board resolution regarding debt forgiveness and capitalization rather than announcing changes in board or management (MANG) or presenting full financial statements (10-K/IR) or an investor presentation (IP). It does not fit any narrow categories like dividend, share transaction, or AGM materials. Therefore it defaults to a general regulatory filing (RNS).
2026-05-13 Spanish
HECHO RELEVANTE. CONDONACION DE DEUDAS CON LOS ACCIONISTAS MAYORITARIOS
Capital/Financing Update Classification · 75% confidence The document is a “Hecho Relevante” notifying regulators of a material financing transaction: majority shareholders irrevocably waiving $808.5m of the company’s debt to rebuild equity. This is not a board change, dividend notice, share issuance, or proxy statement, but rather an update on a capital structure change (debt forgiveness). It therefore fits the Capital/Financing Update category.
2026-05-13 Spanish
AÑO DECLARADO: 2014 - NOMINA DE AUDITORES EXTERNOS
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal statement by an external auditor candidate addressed to the shareholders’ assembly, detailing his independence, qualifications and conditional acceptance for appointment. It is not an audit report on financials, but rather part of the informational package sent to shareholders ahead of voting at a general meeting on auditor designation. This aligns with “Proxy Solicitation & Information Statement” (PSI) for providing information to request votes on meeting proposals.
2026-05-05 Spanish
FECHA DOC.: 05-05-2026 - CUADRO DE REMUNERACIONES - REMUNERACIONES GLOBALES DEL DIRECTORIO
Remuneration Information Classification · 92% confidence The document is a schedule of directors’ remuneration for the fiscal year ended 31/12/2025, detailing amounts and allocations to directors (zero proposed payments, net results, reserves, etc.). This matches the Remuneration Information category, which covers reports detailing compensation for top executives and directors (Code: DEF 14A).
2026-05-05 Spanish
FEC. CONVOC.: 09-04-2026 - CARAC. ASAMBLEA: 5 - CONVOCATORIA A ASAMBLEAS 2
AGM Information Classification · 95% confidence The document contains multiple notices and edicts related to convocations for general assemblies of various companies and cooperatives, including detailed agendas for these meetings such as approval of financial statements, ratification of board members, and other corporate governance matters. These are formal announcements inviting shareholders or associates to attend Annual General Meetings (AGMs) or Ordinary General Meetings. There is no actual financial data, management discussion, or detailed report content present; rather, the document serves to notify stakeholders of upcoming meetings and their agendas. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or related to the Annual General Meeting, including convocations and notices.
2026-04-27 Spanish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.